What is the preferred initial test for Neisseria gonorrhoeae infection and how should specimens be collected from urogenital, pharyngeal, and rectal sites?

Gonorrhea Testing: Preferred Methods and Specimen Collection

Nucleic acid amplification tests (NAATs) are the preferred initial diagnostic test for Neisseria gonorrhoeae infection at urogenital sites, with vaginal specimens (provider or self-collected) in women and urine specimens in men being the optimal specimen sources. 1, 2

Urogenital Testing Approach

Preferred Method: NAATs

• NAATs are the gold standard for genitourinary gonorrhea due to superior sensitivity (>95%) and specificity (>99%) compared to all other methods 2
• FDA-cleared specimen types include: 1, 2
  • Women: Endocervical swabs, vaginal swabs (provider or self-collected), urine
  • Men: Urethral swabs, urine
• Vaginal specimens in women and urine in men are the preferred specimen sources over other options 1
• Transport specimens in laboratory-provided transport devices at room temperature within 2 days 1

Alternative: Culture

• Culture remains acceptable when NAATs are unavailable, requiring endocervical swabs in females or urethral swabs in males 3, 2
• All presumptive N. gonorrhoeae isolates must be confirmed by at least two tests involving different principles 3, 2
• Transport in appropriate medium at room temperature within ≤1 hour; never refrigerate gonorrhea specimens 1
• Culture allows antimicrobial susceptibility testing, which is increasingly important given rising resistance 1

Gram Stain (Limited Use)

• In symptomatic men with urethral discharge only: Gram stain showing polymorphonuclear leukocytes with intracellular gram-negative diplococci is diagnostic with >99% specificity and >95% sensitivity 2
• Never use Gram stain for women, asymptomatic men, or to rule out infection when negative 2

Extragenital Site Testing

Pharyngeal Specimens

• Culture is the most widely available and CDC-recommended method for pharyngeal gonorrhea 2, 4
• NAATs are not FDA-cleared for pharyngeal specimens and may cross-react with commensal Neisseria species in the throat 4
• Some laboratories have validated NAATs for pharyngeal swabs after meeting CLIA requirements, but cross-reactivity remains a concern 4
• Never use Gram stain for pharyngeal specimens due to inadequate sensitivity and specificity 4
• Collect pharyngeal swabs and transport in appropriate medium at room temperature 1

Rectal Specimens

• Culture is generally recommended for rectal gonorrhea, as NAATs are not FDA-cleared for this site 2
• NAATs can be used when laboratories have validated these assays according to CLIA requirements 2
• Testing rectal and pharyngeal sites is recommended in men who have sex with men (MSM) based on sexual practices 1, 3
• Rectal and pharyngeal infections are frequently asymptomatic; 90.8% of extragenital infections would remain undetected if only symptomatic cases were tested 5

Critical Testing Considerations

Comprehensive STI Screening Required

• All patients tested for gonorrhea must be simultaneously tested for chlamydia, syphilis, and HIV 3, 2, 4
• Sexual history should determine all anatomical sites requiring testing (genital, rectal, pharyngeal) based on specific sexual practices 3, 4

Special Populations

• MSM require pharyngeal and rectal testing based on sexual practices, as extragenital infections are common in this population 4, 5
• Pharyngeal infection is more likely in men reporting multiple partners (6-10 partners OR=2.88; >11 partners OR=4.96) and men with HIV (OR=1.78) 5
• Rectal infection is more likely in men with multiple partners, HIV diagnosis, and those practicing receptive anal intercourse without condoms 5

Common Pitfalls to Avoid

• Do not use non-FDA-cleared NAATs for extragenital sites without proper laboratory validation 2
• Do not use Gram stain alone for endocervical, pharyngeal, or rectal specimens 2
• Do not rely on negative Gram stain to rule out infection in asymptomatic men 2
• Do not use nonculture tests (including NAATs) in child sexual abuse cases without confirmation 2
• Confirm with your laboratory which specimen types they accept and have validated, particularly for extragenital sites 1

Test of Cure

• Retesting for test of cure is generally not recommended unless special circumstances exist (pregnancy, continuing symptoms) 1
• All patients diagnosed with gonorrhea should be retested approximately 3 months after treatment due to high reinfection rates 4